Pinz Capital Management, LP Mustang Bio, Inc. Transaction History

Pinz Capital Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.58 - $3.36 $14,964 - $19,488	-5,800 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.7 - $3.81 $64,800 - $91,440	-24,000 Reduced 80.54%	5,800 $19,000
Q1 2021 May 17, 2021	BUY	$3.02 - $5.16 $89,996 - $153,768	29,800 New	29,800 $99,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Pinz Capital Management, LP with notifications on news.